Antibiotic shows promise for treating fragile X syndrome

04/10/2013 | Disability Scoop

Children with fragile X syndrome who received minocycline had modest improvements in anxiety levels and mood-related behaviors compared with a placebo group, researchers report in the Journal of Developmental and Behavioral Pediatrics. Some patients responded better to the medication than others, and researchers are looking for predictive biomarkers.

View Full Article in:

Disability Scoop

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX